Inventor · disambiguated record
George D. Hartman
Also filed as: HARTMAN GEORGE · HARTMAN GEORGE D
178 granted patents·27 pending applications·4,393 citations·filing 1975–2021
99Inventor score
Files withMERCK & CO INC138NOVIRA THERAPEUTICS INC42COLEMAN PAUL J4ARRINGTON KENNETH L3MERCK SHARP & DOHME2
Top patents by PatentIndex Score
205 records- 0199US9181288B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Nov 10, 2015·103 cites·6 claims
- 0298US9579313B2Hepatitis B antiviral agentsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Feb 28, 2017·19 cites·1 claims
- 0398US9400280B2Piperidine derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Jul 26, 2016·24 cites·9 claims
- 0498US9339510B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·25 cites·20 claims
- 0598US9205079B2Hepatitis B antiviral agentsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·25 cites·18 claims
- 0698US8993771B2Hepatitis B antiviral agentsNOVIRA THERAPEUTICS INC·Filed 2014·Granted Mar 31, 2015·36 cites·18 claims
- 0798US6313138B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2001·Granted Nov 6, 2001·130 cites·32 claims
- 0898US6306874B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Oct 23, 2001·214 cites·36 claims
- 0997US9550779B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Jan 24, 2017·10 cites·17 claims
- 1097US9527845B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Dec 27, 2016·11 cites·19 claims
- 1197US9518057B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Dec 13, 2016·10 cites·20 claims
- 1297US9066932B2Hepatitis B antiviral agentsNOVIRA THERAPEUTICS INC·Filed 2013·Granted Jun 30, 2015·39 cites·29 claims
- 1397US9061008B2Hepatitis B antiviral agentsNOVIRA THERAPEUTICS INC·Filed 2013·Granted Jun 23, 2015·39 cites·18 claims
- 1497US6794393B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Sep 21, 2004·75 cites·3 claims
- 1597US5856326AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted Jan 5, 1999·280 cites·13 claims
- 1696US9676747B2Hepatitis B antiviral agentsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Jun 13, 2017·20 cites·18 claims
- 1796US9505722B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·24 cites·20 claims
- 1896US9169212B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·28 cites·20 claims
- 1996US6875767B2(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Apr 5, 2005·87 cites·7 claims
- 2096US6586423B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jul 1, 2003·151 cites·8 claims
- 2196US6420382B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2001·Granted Jul 16, 2002·120 cites·30 claims
- 2296US6048861AIntegrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted Apr 11, 2000·100 cites·47 claims
- 2396US5854245AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1997·Granted Dec 29, 1998·103 cites·10 claims
- 2496US5719144AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1995·Granted Feb 17, 1998·77 cites·24 claims
- 2595US8629274B2Hepatitis B antiviral agentsHARTMAN GEORGE D·Filed 2012·Granted Jan 14, 2014·49 cites·22 claims
- 2695US6927293B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Aug 9, 2005·69 cites·2 claims
- 2795US6586424B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jul 1, 2003·95 cites·8 claims
- 2895US6066738AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted May 23, 2000·94 cites·20 claims
- 2995US5814643ASulfonamide fibrinogen receptor antagonistsMERCK & CO INC·Filed 1997·Granted Sep 29, 1998·48 cites·12 claims
- 3095US5227490AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1992·Granted Jul 13, 1993·73 cites·15 claims
- 3195US4897402A5-oxa, 5-thia, 5-aza HmG-CoA reductase inhibitorsMERCK & CO INC·Filed 1988·Granted Jan 30, 1990·54 cites·18 claims
- 3295US4735956ACertain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockersMERCK & CO INC·Filed 1985·Granted Apr 5, 1988·53 cites·7 claims
- 3394US5968965AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Oct 19, 1999·85 cites·15 claims
- 3494US4963538A5-oxygenated HMG-CoA reductase inhibitorsMERCK & CO INC·Filed 1989·Granted Oct 16, 1990·46 cites·20 claims
- 3594US4940727ANovel HMG-CoA reductase inhibitorsMERCK & CO INC·Filed 1988·Granted Jul 10, 1990·52 cites·25 claims
- 3693US5281585AFibrinogen receptor antagonists for inhibiting aggregation of blood plateletsMERCK & CO INC·Filed 1992·Granted Jan 25, 1994·107 cites·18 claims
- 3792US10544141B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·2 cites·21 claims
- 3892US10538519B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·2 cites·13 claims
- 3992US10189835B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2017·Granted Jan 29, 2019·2 cites·18 claims
- 4091US10556904B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2018·Granted Feb 11, 2020·2 cites·20 claims
- 4191US10093669B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2016·Granted Oct 9, 2018·2 cites·10 claims
- 4291US10077264B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2016·Granted Sep 18, 2018·2 cites·17 claims
- 4391US9890161B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2016·Granted Feb 13, 2018·3 cites·18 claims
- 4491US7632839B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2006·Granted Dec 15, 2009·19 cites·4 claims
- 4591US6958340B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Oct 25, 2005·73 cites·12 claims
- 4691US5292756ANovel sulfonamide fibrinogen receptor antagonistsMERCK & CO INC·Filed 1992·Granted Mar 8, 1994·56 cites·16 claims
- 4791US5130306A5-Oxygenated HMG-COA reductase inhibitorsMERCK & CO INC·Filed 1990·Granted Jul 14, 1992·49 cites·19 claims
- 4891US5116870AHMG-CoA reductase inhibitorsMERCK & CO INC·Filed 1990·Granted May 26, 1992·62 cites·25 claims
- 4991US5098931A7-substituted HMG-CoA reductase inhibitorsMERCK & CO INC·Filed 1990·Granted Mar 24, 1992·49 cites·10 claims
- 5090US6410526B1αv integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Jun 25, 2002·40 cites·28 claims
Showing the top 50 of 205 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when George D. Hartman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →